| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $491.7M | +23.5% |
| Cost of Revenue | $68.8M | +32.5% |
| R&D Expense | $12.6M | -86.4% |
| SG&A Expense | $177.7M | +32.9% |
| Operating Income | $195.1M | +124.8% |
| Pre-tax Income | $216.3M | +128.8% |
| Income Tax | $52.4M | +126.7% |
| Net Income | $163.9M | +129.5% |
| EPS (Basic) | $1.38 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $517.6M | +276.0% |
| Accounts Receivable | $65.5M | +22.4% |
| Inventory | $19.5M | +24.9% |
| Current Assets | $623.6M | +184.3% |
| Total Assets | $851.4M | +81.1% |
| Current Liabilities | $120.7M | +58.7% |
| Total Liabilities | $123.8M | +50.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $239.8M | +67.0% |
| Capital Expenditures | $556K | +140.7% |
| Investing Cash Flow | -$556K | +99.8% |
| Financing Cash Flow | $140.7M | +1395.6% |
| Free Cash Flow | $239.3M | +66.9% |
| +106.0% |
| EPS (Diluted) | $1.31 | +107.9% |
| Stockholders' Equity |
| $727.6M |
| +87.6% |